FDA
-
-
-
-
-
-
-
Aptose Presents Highlights from Clinical Update
-
-
-
-
-
-
-
Aptose Biosciences (APTO) Granted FDA Fast Track Designation for HM43239
-
-
-
-
-
-
-
Aptose Reports Results for the Second Quarter 2020
-
-
-
-
-
-
-
Aptose Reports Results for the Second Quarter Ended June 30, 2019
-
-
-
-
-
-
-
Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806
-
-
-
-
-
-
-
Aptose Biosciences (APTO) Reports Lift of FDA Clinical Hold on APTO-253
-
-
-
-
-
-
-
Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

